"Modern Chinese medicine industry" brand 
 
 
Pharmaceutical industry information conference opened in chengdu The high-tech zone will develop biological medicine industry 
 
  
Source: author: chengdu search all news Publisher: Zhang Jian thill date: 2015-07-14 

    Today, by the ministry of industry and information technology, Chinese medicine enterprise management association and China pharmaceutical industry research institute, chengdu city government support, China's pharmaceutical industry information center and chengdu high-tech zone administrative committee held in 2015 (32nd) national pharmaceutical industry information meeting held in chengdu, more than 1000 government competent leadership from the pharmaceutical industry, industry experts and executives, to discuss the pharmaceutical industry development in the future.
 
    This conference to "micro revolution e + new ecological health" as the theme, closely around the medicine latest policy, industry trends, research and development, marketing, investment and financing, merger and acquisition, Internet +, etc, to research and development, marketing, mergers and acquisitions investment and Internet BBS four points as the core, supplemented by miit "pharmaceutical industry much starker choices-and graver consequences-in planning" symposium, as well as the drug safety "dialogue", "medicine", "dialogue YiXie" such a closed-door meeting. Executives from top pharmaceutical companies at home and abroad will share the enterprise to judge and deal with the trend of the development of the industry.
 
    Chengdu biological pharmaceutical industry strong foundation
 
    Chengdu biological pharmaceutical industry and has deep roots, the industry known as "not sichuan medicine into" praise. Chengdu rules on biological medicine industrial enterprise main business income of 9.24 billion yuan, from 2005 increased year by year in 2014 to 35.34 billion yuan, the average annual growth of 18%. In terms of structure, is mainly composed of biological products, chemical medicine, modern traditional Chinese medicine and medical equipment of four major parts. In terms of products, infusion, blood products, etc. Some products in the domestic market share is higher, compaq heap eye ophthalmic injection, hundred yu lactones ginkgo biloba injection, mondial kang products such as leading technology. In terms of resources, with a large number of sichuan university institutes of colleges and universities, scientific research institutions, has the domestic first-class pharmacodynamic evaluation, safety evaluation, a clinical trial research base and translational medicine research and development service ability. In addition, the location in the city of chengdu and living environment, the respect such as medicinal material resources and human resources also has its own unique advantages.
 
    As the conference partner of chengdu high-tech zone is the first batch of national high-tech industrial development zone, is the national "create a world-class high-tech park" one of the first pilot of six. After years of development, chengdu high-tech zone has gathered 773 biological medicine enterprises, formed a pharmaceutical and medical engineering industry cluster. "Biological medicine industry has been the important support of chengdu high-tech zone, since the years of development, has formed chemical medicine, biological medicine, medical equipment, wisdom, health and other fields, forms, integrates various types of research and development, test, clinical and financial resources platform, through the enterprise from the growth of the industrialization of research and development to clinical channel, form the innovative research and development as the core, the technology, finance and supporting policy, market, enterprise and all kinds of industrial ecosystem services and blend with each other." The relevant person in charge of chengdu high-tech zone said.
 
    According to introducing, chengdu high-tech zone produced the first access to the eu with independent intellectual property rights therapeutic drugs mondial, occupy the hepatitis b immunoglobulin exports half rong was born, with the largest domestic lead compounds library pilot drugs, developed China's first with completely independent intellectual property rights of superconducting magnetic resonance imaging systems, such as the Thai health a batch of outstanding enterprises. Within the chengdu high-tech zone, so far there are in research project (drugs and medical devices) more than 200, among them, including mondial nine acquisitive vial multi-function apoptosis agonists (DATR), chapter nine biological anti-cancer chemical class of new drugs Vial of chlorogenic acid in clinical stages, such as a class of new drugs.
 
    Chengdu high-tech zone will develop the biological medicine industry
 
    "With the chengdu high-tech zone approved by the national independent innovation demonstration area, biological medicine industry will gain more opportunities in chengdu high-tech zone." The relevant person in charge of chengdu high-tech zone, said the next step, chengdu high-tech zone will develop the biological medicine industry. Formulated according to "three business development plan," predicts 2020, the chengdu high-tech zone of biological medicine industry revenue is expected to reach 100 billion yuan, become a new highland biological medicine industry in China.
 
    Investment promotion and capital introduction, chengdu high-tech zone "for enterprises" and "hiring variety", "made for" and "recruiting service". Focused on biological medicine industry of the world top 500, industry top ten enterprises, benchmarking, the major innovation of industrial projects, and aiming at the steering will guide the whole construction machinery, the key link of the industrial chain.
 
    In the aspect of industry development, make the enterprises, encourage enterprises to strengthen innovation ability, to increase support for innovation varieties, improve enterprise competitiveness, encourage enterprises to become bigger and stronger. In terms of development carrier, planning a high level and comprehensive major medical park, focused on building high west biological medicine industrial clusters, new biological industry group in sichuan, sichuan biomedical innovation incubation park. Seek cooperation with the rest area cities and counties in chengdu, using their environmental loads is larger, the characteristics of land resources more fully, joint construction to meet the requirements of GAP planting base of Chinese medicinal materials.
 
    In the aspect of development path, in combination with existing resources of land resources, building in the zone and the surrounding the medicine and medical engineering "dual-core", pharmaceutical e-commerce and large health industry "two wings", will be promote to build high-tech biological industry as a whole. The key in the pharmaceutical industry cluster "biotechnology drugs" areas, to build "new vaccines, antibodies and other proteins and polypeptide drugs" and "modern Chinese medicine industry" brand; In medical engineering industry cluster "medical equipment", highlighting "equipment" and "diagnostics" industry brand.
 
    In the aspect of development environment, it is the perfect park service mechanism, subdividing service enterprises. The second is for enterprise capital operation, research and development test, scale production, medicine certificate examination and approval, market the logistics of the whole industry chain processes, set up the whole industry chain service platform in the park. Three is actively introduce authority in the field of medicine and national detection, recognition and examination and approval authority, reduce the cost in the process of enterprise during the reporting.